Der globale Markt für die Herstellung von Stammzellen wurde im Jahr 2022 auf 12,58 Milliarden geschätzt und soll bis 2029 21,57 Milliarden erreichen, was einem CAGR von 9,4 % von 2022 bis 2029 entspricht.
Die Entwicklung verschiedener Arten von Medikamenten sowie die Untersuchung der chemischen Wirkung von Medikamenten auf verschiedene Zellen und Gewebe und die Feststellung, ob diese Medikamente beschädigte Zellen oder Gewebe reparieren oder ersetzen können, erfolgen alle mithilfe von Stammzellen, die aus Blutzellen oder Knochenmarkfragmenten gewonnen werden. Dieser Markt ist derzeit im Entstehen und Trend.
| ATTRIBUT | DETAILS |
| Studiendauer | 2022–2029 |
| Basisjahr | 2021 |
| Geschätztes Jahr | 2022 |
| Voraussichtliches Jahr | 2022–2029 |
| Historischer Zeitraum | 2018-2020 |
| Einheit | Wert (Milliarden USD) |
| Segmentierung | Nach Produkt, nach Anwendung, nach Endbenutzer und nach Region. |
| Nach Produkt |
|
| Nach Anwendung |
|
| Durch Endbenutzer |
|
| Nach Region |
|
Stammzellen sind für die Behandlung von Krankheiten sowie für spezielle Forschungsprojekte wie genetische Tests und personalisierte Therapien unverzichtbar. Öffentliche und private Interessenvertreter finanzieren die Entwicklung stammzellenbasierter Technologien zunehmend, da sie sich des therapeutischen Potenzials von Stammzellen und des Mangels an wirksamen Behandlungen für seltene Krankheiten immer bewusster werden.
Die wachsende ältere Bevölkerung und die steigende Zahl an Krebserkrankungen werden einen erheblichen Einfluss auf die Entwicklung der Stammzellenherstellungsbranche haben . Zu den Faktoren, die die Expansion des Stammzellenherstellungsmarktes ankurbeln, gehören darüber hinaus die zunehmende Urbanisierung und das verfügbare persönliche Einkommen. Darüber hinaus sind steigende Ausgaben für die Gesundheitsinfrastruktur einer der wichtigsten Branchenfaktoren, die den Markt für die Stammzellenherstellung noch weiter vorantreiben werden. Darüber hinaus wird das Wachstumstempo des Marktes durch das wachsende öffentliche Bewusstsein für die therapeutische Wirksamkeit von Stammzellenprodukten gebremst.
The global Stem Cell Manufacturing market was valued at 12.58 billion in 2022 and is projected to reach 21.57 billion by 2029, growing at a CAGR of 9.4% from 2022 to 2029
Based on product, application, end-user, and region the stem cell manufacturing market report's divisions are broken down.
The global Stem Cell Manufacturing market registered a CAGR of 9.4% from 2022 to 2029. The industry segment was the highest revenue contributor to the market.
Key players profiled in the report include Thermo Fisher Scientific, Merck Millipore, Lonza Group AG, Danaher Corporation, Sartorius AG, Bio-Rad Laboratories, Becton, Dickinson and Company, Stemcell Technologies, Fujifilm Holdings Corporation, Miltenyi Biotec, Terumo BCT Inc., Corning Inc., Bio-Techne Corporation, Takara Bio Group, Eppendorf AG, Getinge, Himedia Laboratories, Anterogen, Cellgenix GMBH, and Promocell.
The stem cell manufacturing market was dominated by North America in 2020, followed by Europe. The development of the stem cell manufacturing market in North America is also supported by elements like the region's strong research infrastructure, growing public awareness regarding the therapeutic potential of stem cells in efficient disease management, and rising adoption of novel stem cell therapies in the US.
Based on product, application, end user and region, the global market for professional Stem Cell Manufacturing is divided into these categories.
Consumables, instruments, and stem cell lines make up the market segments for stem cell manufacturing according to the product. The market for stem cell production has a section called stem cell lines that is expanding at the quickest rate. The demand for functionally potent stem cell lines in research, the increasing acceptance of stem cell-based medicinal products in the US, Europe, and Asia, and the development of novel stem cell culture & preservation techniques are the primary drivers of market expansion.
In terms of application, the clinical applications sector held the second-largest market share for stem cell production in 2020.
The stem cell manufacturing market is divided into three application categories based on use: research, clinical, and cell & tissue banking. The growing understanding of stem cells' therapeutic potential in the management of effective disease, technological developments in genome-based cell analysis and other stem cell manufacturing techniques and improving infrastructure for stem cell processing and preservation are the main drivers of the demand for stem cell-based products in clinical applications.
In terms of end users, pharmaceutical and biotechnology firms held the greatest market share for stem cell production in 2020.
The pharmaceutical and biotechnology industries, academic institutions, research laboratories, and contract research organizations, hospitals and surgical centers, cell banks and tissue banks, and other end users are the market segments for stem cell manufacturing based on end users. In 2020, the pharmaceutical and biotechnology industries predominated. Major end customers of stem cell products include pharmaceutical and biotechnology firms. For internal clinical research and medication discovery activities, these goods are used. Stem cell-based research is receiving more private funding, which is what is essentially driving the demand for stem cell products among pharma-biotech businesses.
[caption id="attachment_16526" align="aligncenter" width="1920"]
The major players operating in the global Stem Cell Manufacturing industry include the major market players include Thermo Fisher Scientific, Merck Millipore, Lonza Group AG, Danaher Corporation, Sartorius AG, Bio-Rad Laboratories, Becton, Dickinson and Company, Stemcell Technologies, Fujifilm Holdings Corporation, Miltenyi Biotec, Terumo BCT Inc., Corning Inc., Bio-Techne Corporation, Takara Bio Group, Eppendorf AG, Getinge, Himedia Laboratories, Anterogen, Cellgenix GMBH, and Promocell.
Industry Development
20 April 2022: The PPD clinical research business of Thermo Fisher Scientific Inc. and Matrix Clinical Trials, a Matrix Medical Network offering, are collaborating to bring clinical trials to patients with an innovative decentralized clinical trial (DCT) solution. 23 January 2023: Two global leaders are joining strengths in a broad new effort to advance the discovery and innovation needed to address complex scientific challenges. The University of California San Diego and Thermo Fisher Scientific have agreed to form a transformational 10-year strategic partnership that leverages the leading expertise of each organization.Geographically, the Stem Cell Manufacturing market is segmented into North America, South America, Europe, APAC, and MEA.
The stem cell manufacturing market was dominated by North America in 2020, followed by Europe. The development of the stem cell manufacturing market in North America is also supported by elements like the region's strong research infrastructure, growing public awareness regarding the therapeutic potential of stem cells in efficient disease management, and rising adoption of novel stem cell therapies in the US. However, this industry is being constrained by strict rules governing ESCs and iPSC-based clinical research as well as fierce market competition from other therapeutic technologies (including gene therapy, drug-based treatment, and tissue and organ transplantation).
Want to know more about the report or any specific requirement?
We asked them to research ‘ Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
We asked them to research ‘Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
Our Report’s database covers almost all topics of all regions over the Globe.
Tie ups with top publishers around the globe.
Complete pre and post sales support.
Complete secure payment process.